Mandate

Vinge advises Gunnebo in connection with the divestment of its Cash Management business

Vinge advises Gunnebo Aktiebolag (“Gunnebo”) in connection with the divestment of its Cash Management business to Sesami Cash Management Technologies Corporation, a cash ecosystem solution company controlled by GardaWorld Security Corporation.

The Cash Management business includes automated cash handling solutions, software and services for closed cash handling, cash recycling and cash deposit, for the purpose of creating a safer and more efficient cash cycle and reducing the cost of handling notes and coins.

The divestment is part of Gunnebo’s transformation journey started in 2020, leaving the integrated security and the cash management segments, to be able to focus on the global leading market positions within the business units Entrance Control and Safe Storage.

The transaction is expected to be closed by 1 March 2022.

Vinge’s team consisted of Christina Kokko, Matthias Pannier, Maria Dahlin Kolvik, Viktor Lennartsson and Nina Fathjalali (M&A), Mathilda Persson and Martin Boström (Commercial Agreements/IT), Stojan Arnerstål and Michael Montner (IP), and Cathrin Larsson, Sara Dahlros Sköld and Christoffer Widström (VDR).

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025